Healthcare provider profile · identity verified

Heberto Garza, M.D.

Internal Medicine · SAN ANTONIO, TX · NPI 1487656427

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	625	142
Rosuvastatin Calcium	Rosuvastatin Calcium	503	135
Atorvastatin Calcium	Atorvastatin Calcium	451	118
Losartan Potassium	Losartan Potassium	451	109
Amlodipine Besylate	Amlodipine Besylate	294	75
Pantoprazole Sodium	Pantoprazole Sodium	253	114
Metformin Hcl	Metformin Hcl	237	62
Alprazolam	Alprazolam	227	54
Lisinopril	Lisinopril	172	43
Omeprazole	Omeprazole	166	43
Trazodone Hcl	Trazodone Hcl	156	28
Gabapentin	Gabapentin	147	43
Zolpidem Tartrate	Zolpidem Tartrate	138	28
Ezetimibe	Ezetimibe	137	33
Sertraline Hcl	Sertraline Hcl	133	29
Albuterol Sulfate Hfa	Albuterol Sulfate	128	51
Montelukast Sodium	Montelukast Sodium	127	36
Potassium Chloride	Potassium Chloride	127	34
Metoprolol Succinate	Metoprolol Succinate	126	32
Olmesartan Medoxomil	Olmesartan Medoxomil	118	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	113	82
Furosemide	Furosemide	113	37
Tamsulosin Hcl	Tamsulosin Hcl	102	30
Methylprednisolone	Methylprednisolone	98	78
Fluticasone Propionate	Fluticasone Propionate	97	43
Escitalopram Oxalate	Escitalopram Oxalate	95	26
Pravastatin Sodium	Pravastatin Sodium	91	22
Tramadol Hcl	Tramadol Hcl	91	29
Metformin Hcl Er	Metformin Hcl	90	24
Carvedilol	Carvedilol	89	21
Hydrochlorothiazide	Hydrochlorothiazide	87	26
Synthroid	Levothyroxine Sodium	85	20
Metoprolol Tartrate	Metoprolol Tartrate	84	24
Eliquis	Apixaban	80	15
Clonazepam	Clonazepam	78	12
Glimepiride	Glimepiride	70	17
Allopurinol	Allopurinol	64	18
Lorazepam	Lorazepam	63	13
Azithromycin	Azithromycin	60	48
Spironolactone	Spironolactone	60	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	15
Finasteride	Finasteride	57	17
Duloxetine Hcl	Duloxetine Hcl	56	15
Donepezil Hcl	Donepezil Hcl	55	15
Citalopram Hbr	Citalopram Hydrobromide	54	11
Jardiance	Empagliflozin	54	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	12
Alendronate Sodium	Alendronate Sodium	50	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	48	46
Simvastatin	Simvastatin	48	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	36
Bupropion Xl	Bupropion Hcl	46	suppressed
Mounjaro	Tirzepatide	46	suppressed
Nifedipine Er	Nifedipine	46	11
Vitamin D2	Ergocalciferol (Vitamin D2)	44	12
Chlorthalidone	Chlorthalidone	43	11
Meloxicam	Meloxicam	42	suppressed
Ozempic	Semaglutide	39	suppressed
Baclofen	Baclofen	38	12
Buspirone Hcl	Buspirone Hcl	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	12
Valacyclovir	Valacyclovir Hcl	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Mirtazapine	Mirtazapine	32	suppressed
Mupirocin	Mupirocin	32	26
Prednisone	Prednisone	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	16
Colchicine	Colchicine	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	13
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Temazepam	Temazepam	27	suppressed
Nebivolol Hcl	Nebivolol Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	20
Farxiga	Dapagliflozin Propanediol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Famotidine	Famotidine	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	14
Ibandronate Sodium	Ibandronate Sodium	21	suppressed
Liothyronine Sodium	Liothyronine Sodium	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Diazepam	Diazepam	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Glipizide	Glipizide	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Valsartan	Valsartan	19	suppressed
Metolazone	Metolazone	18	suppressed
Metronidazole	Metronidazole	18	13
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Edarbi	Azilsartan Medoxomil	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Ondansetron Odt	Ondansetron	16	14
Ramipril	Ramipril	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Topiramate	Topiramate	15	suppressed
Atenolol	Atenolol	14	suppressed
Estradiol	Estradiol	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Paricalcitol	Paricalcitol	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Primidone	Primidone	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Triamterene	Triamterene	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error